Theralase Technologies Company Insiders
| TLT Stock | CAD 0.26 0.01 3.70% |
Theralase Technologies employs about 7 people. The company is managed by 7 executives with a total tenure of roughly 19 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Recap of Theralase Technologies' management performance can provide insight into the venture performance.
| Roger DumoulinWhite CEO President CEO, Director |
Theralase |
Theralase Technologies Management Team Effectiveness
The company has return on total asset (ROA) of (0.8188) % which means that it has lost $0.8188 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (2.3855) %, meaning that it generated substantial loss on money invested by shareholders. Theralase Technologies' management efficiency ratios could be used to measure how well Theralase Technologies manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.46 in 2024. Return On Capital Employed is likely to drop to -2.19 in 2024. At this time, Theralase Technologies' Total Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 966 K in 2024, whereas Total Current Assets are likely to drop slightly above 1.4 M in 2024.Common Stock Shares Outstanding is likely to climb to about 231 M in 2024, whereas Net Loss is likely to drop (4.9 M) in 2024.
Theralase Technologies Workforce Comparison
Theralase Technologies is currently under evaluation in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 1.11 Million. Theralase Technologies adds roughly 0.0 in number of employees claiming only tiny portion of equities under Health Care industry.
Theralase Technologies Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Theralase Technologies Price Series Summation is a cross summation of Theralase Technologies price series and its benchmark/peer.
Theralase Technologies Notable Stakeholders
A Theralase Technologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Theralase Technologies often face trade-offs trying to please all of them. Theralase Technologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Theralase Technologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Roger DumoulinWhite | President CEO, Director | Profile | |
| David BA | President Division | Profile | |
| Lori Leach | Marketing Consultant | Profile | |
| Terry DVM | Equine Consultant | Profile | |
| DSc MD | Chief CEO | Profile | |
| Vaughn Wyant | Marketing Consultant | Profile | |
| Kristina CPA | CFO Director | Profile |
About Theralase Technologies Management Performance
The success or failure of an entity such as Theralase Technologies often depends on how effective the management is. Theralase Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Theralase management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Theralase management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.39) | (1.46) | |
| Return On Capital Employed | (2.09) | (2.19) | |
| Return On Assets | (1.39) | (1.46) | |
| Return On Equity | (2.40) | (2.28) |
Please note, the imprecision that can be found in Theralase Technologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Theralase Technologies. Check Theralase Technologies' Beneish M Score to see the likelihood of Theralase Technologies' management manipulating its earnings.
Theralase Technologies Workforce Analysis
Traditionally, organizations such as Theralase Technologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Theralase Technologies within its industry.Theralase Technologies Manpower Efficiency
Return on Theralase Technologies Manpower
| Revenue Per Employee | 152.9K | |
| Revenue Per Executive | 152.9K | |
| Net Loss Per Employee | 653K | |
| Net Loss Per Executive | 653K | |
| Working Capital Per Employee | 60.2K | |
| Working Capital Per Executive | 60.2K |
Additional Tools for Theralase Stock Analysis
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.